...
首页> 外文期刊>Vaccine >Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age
【24h】

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age

机译:评估2-7个月大的婴儿7价肺炎球菌结合物,DTaP.IPV / PRP-T Hib和乙型肝炎疫苗的共用性

获取原文
获取原文并翻译 | 示例
           

摘要

This study assessed compatibility of concurrently administered 7-valent pneumococcal conjugate (PCV7), hepatitis B (HB) and DTaP.IPV/Hib vaccines. Infants were given DTaP.IPV/Hib and HB at 2, 4, 6 months and randomly assigned (2:1) to receive PCV7 concurrently or sequentially (at 3, 5, 7 months). Antibody levels were compared in 246 concurrent and 122 sequential vaccinees. Responses to PCV7, DTaP.IPV/Hib and HB were generally unaltered with concurrent administration except that Hib responses were increased (p=0.008) and HB responses were reduced (p=0.006) with concurrent dosing, the latter possibly from same thigh injection with DTaP.IPV/Hib. We conclude that PCV7, DTaP.IPV/Hib and HB are compatible with concurrent, separate injections.
机译:这项研究评估了同时使用的7价肺炎球菌结合物(PCV7),乙型肝炎(HB)和DTaP.IPV / Hib疫苗的相容性。分别于2、4、6个月给婴儿提供DTaP.IPV / Hib和HB,并随机分配(2:1)同时或相继(3、5、7个月)接受PCV7。比较了246种同时接种和122种连续接种疫苗的抗体水平。并发给药对PCV7,DTaP.IPV / Hib和HB的反应通常不变,但并发给药增加了Hib响应(p = 0.008)和HB响应降低(p = 0.006),后者可能是通过同时注射大腿DTaP.IPV / Hib。我们得出结论,PCV7,DTaP.IPV / Hib和HB与并发的单独注射剂相容。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号